SPECGX LLC FDA Approval NDA 021011

NDA 021011

SPECGX LLC

FDA Drug Application

Application #021011

Documents

Letter2000-08-31
Label2000-08-31
Label2009-06-07
Letter2009-02-24
Letter2009-05-20
Label2009-02-24
Review2004-03-10
Letter2016-12-20
Label2016-12-21
Letter2018-09-28
Letter2018-09-28
Label2018-10-12
Label2018-10-12
Label2019-10-08
Medication Guide2019-10-08
Letter2019-10-08
Letter2021-03-05
Label2021-03-08
Medication Guide2021-03-08

Application Sponsors

NDA 021011SPECGX LLC

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL15MG1ROXICODONEOXYCODONE HYDROCHLORIDE
002TABLET;ORAL30MG1ROXICODONEOXYCODONE HYDROCHLORIDE
003TABLET;ORAL5MG1ROXICODONEOXYCODONE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2000-08-31STANDARD
LABELING; LabelingSUPPL2AP2009-02-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2009-05-15N/A
LABELING; LabelingSUPPL6AP2016-12-16STANDARD
REMS; REMSSUPPL8AP2018-09-18N/A
LABELING; LabelingSUPPL9AP2018-09-18STANDARD
LABELING; LabelingSUPPL10AP2019-10-07STANDARD
LABELING; LabelingSUPPL11AP2021-03-04STANDARD

Submissions Property Types

ORIG1Null31
SUPPL6Null15
SUPPL8Null7
SUPPL9Null15
SUPPL10Null6
SUPPL11Null6

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

SPECGX LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21011
            [companyName] => SPECGX LLC
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021011s010lbl.pdf#page=28"]
            [products] => [{"drugName":"ROXICODONE","activeIngredients":"OXYCODONE HYDROCHLORIDE","strength":"15MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"},{"drugName":"ROXICODONE","activeIngredients":"OXYCODONE HYDROCHLORIDE","strength":"30MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"ROXICODONE","activeIngredients":"OXYCODONE HYDROCHLORIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"10\/07\/2019","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021011s010lbl.pdf\"}]","notes":""},{"actionDate":"10\/07\/2019","submission":"SUPPL-10","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021011s010lbl.pdf\"}]","notes":""},{"actionDate":"09\/18\/2018","submission":"SUPPL-9","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/021011s008s009lbl.pdf\"}]","notes":""},{"actionDate":"09\/18\/2018","submission":"SUPPL-8","supplementCategories":"REMS - PROPOSAL - D-N-A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/021011s008s009lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021011s006lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-6","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021011s006lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021011s006lbl.pdf\"}]","notes":""},{"actionDate":"05\/15\/2009","submission":"SUPPL-3","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/021011s003lbl.pdf\"}]","notes":""},{"actionDate":"05\/15\/2009","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/021011s003lbl.pdf\"}]","notes":""},{"actionDate":"02\/20\/2009","submission":"SUPPL-2","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/021011s002lbl.pdf\"}]","notes":""},{"actionDate":"08\/31\/2000","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2000\\\/21011lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ROXICODONE","submission":"OXYCODONE HYDROCHLORIDE","actionType":"15MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ROXICODONE","submission":"OXYCODONE HYDROCHLORIDE","actionType":"30MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ROXICODONE","submission":"OXYCODONE HYDROCHLORIDE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-10-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.